Published on: 17 July 2023
This guideline provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only contraceptive pills. It is intended for any health care professional or health service providing contraceptive care in the UK.
Please read this guidance document in conjunction with any relevant clinical statements for this topic:
FSRH Response to new study on use of CHC and POC and breast cancer risk (March 2023)
FSRH CEU Statement: Oral Contraceptives and Multiple Sclerosis (March 2014)
FSRH CEU Statement: Contraception and Weight Gain (August 2019)
Also available in digital format on the BMJ website: FSRH Guideline (August 2022) Progestogen-only Pills. BMJ Sexual & Reproductive Health 2022; 48:Suppl 1.
Your download should start automatically. If not download directly.